448 related articles for article (PubMed ID: 31523180)
1. Elevated plasma S100A1 level is a risk factor for ST-segment elevation myocardial infarction and associated with post-infarction cardiac function.
Fan L; Liu B; Guo R; Luo J; Li H; Li Z; Xu W
Int J Med Sci; 2019; 16(8):1171-1179. PubMed ID: 31523180
[TBL] [Abstract][Full Text] [Related]
2. Predictors of left ventricular remodeling after ST-elevation myocardial infarction.
Hendriks T; Hartman MHT; Vlaar PJJ; Prakken NHJ; van der Ende YMY; Lexis CPH; van Veldhuisen DJ; van der Horst ICC; Lipsic E; Nijveldt R; van der Harst P
Int J Cardiovasc Imaging; 2017 Sep; 33(9):1415-1423. PubMed ID: 28389968
[TBL] [Abstract][Full Text] [Related]
3. NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome.
Castro LR; Alencar MC; Barbosa MM; Nunes Mdo C; Cardoso JR; Ribeiro AL
Arq Bras Cardiol; 2011 Dec; 97(6):456-61. PubMed ID: 22030563
[TBL] [Abstract][Full Text] [Related]
4. Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.
Feistritzer HJ; Reinstadler SJ; Klug G; Reindl M; Wöhrer S; Brenner C; Mayr A; Mair J; Metzler B
BMC Cardiovasc Disord; 2016 Nov; 16(1):239. PubMed ID: 27894261
[TBL] [Abstract][Full Text] [Related]
5. Multibiomarker analysis in patients with acute myocardial infarction.
Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
[TBL] [Abstract][Full Text] [Related]
6. Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction.
Tiller C; Reindl M; Holzknecht M; Klapfer M; Beck A; Henninger B; Mayr A; Klug G; Reinstadler SJ; Metzler B
Eur J Intern Med; 2019 Jun; 64():57-62. PubMed ID: 30878297
[TBL] [Abstract][Full Text] [Related]
7. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of High Sensitivity Troponin T to Predict Long-Term Left Ventricular Dysfunction After ST-Elevation Myocardial Infarction.
Mohammad MA; Koul S; Lønborg JT; Nepper-Christensen L; Høfsten DE; Ahtarovski KA; Bang LE; Helqvist S; Kyhl K; Køber L; Kelbæk H; Vejlstrup N; Holmvang L; Schoos MM; Göransson C; Engstrøm T; Erlinge D
Am J Cardiol; 2020 Nov; 134():8-13. PubMed ID: 32933755
[TBL] [Abstract][Full Text] [Related]
9. Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?
Ezekowitz JA; Théroux P; Welsh R; Bata I; Webb J; Armstrong PW
Can J Physiol Pharmacol; 2007 Jan; 85(1):173-8. PubMed ID: 17487257
[TBL] [Abstract][Full Text] [Related]
10. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.
Hartman MHT; Eppinga RN; Vlaar PJJ; Lexis CPH; Lipsic E; Haeck JDE; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Clin Cardiol; 2017 May; 40(5):322-328. PubMed ID: 28026027
[TBL] [Abstract][Full Text] [Related]
11. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome.
Ogawa A; Seino Y; Yamashita T; Ogata K; Takano T
Circ J; 2006 Nov; 70(11):1372-8. PubMed ID: 17062956
[TBL] [Abstract][Full Text] [Related]
12. Low-Level Tragus Stimulation for the Treatment of Ischemia and Reperfusion Injury in Patients With ST-Segment Elevation Myocardial Infarction: A Proof-of-Concept Study.
Yu L; Huang B; Po SS; Tan T; Wang M; Zhou L; Meng G; Yuan S; Zhou X; Li X; Wang Z; Wang S; Jiang H
JACC Cardiovasc Interv; 2017 Aug; 10(15):1511-1520. PubMed ID: 28797427
[TBL] [Abstract][Full Text] [Related]
13. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
14. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
Er F; Dahlem KM; Nia AM; Erdmann E; Waltenberger J; Hellmich M; Kuhr K; Le MT; Herrfurth T; Taghiyev Z; Biesenbach E; Yüksel D; Eran-Ergöknil A; Vanezi M; Caglayan E; Gassanov N
JACC Cardiovasc Interv; 2016 Feb; 9(3):231-240. PubMed ID: 26847114
[TBL] [Abstract][Full Text] [Related]
15. Time-Dependent Change in Omentin-1 Level Correlated with Early Improvement of Myocardial Function in Patients with First Anterior ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention.
Zhu Y; Hu C; Du Y; Zhang J; Liu J; Cheng G; Han H; Zhao Y
J Atheroscler Thromb; 2019 Oct; 26(10):856-867. PubMed ID: 30853697
[TBL] [Abstract][Full Text] [Related]
16. The Usefulness of Admission Plasma NT-pro BNP Level to Predict Left Ventricular Aneurysm Formation after Acute ST-Segment Elevation Myocardial Infarction.
Celebi S; Celebi OO; Cetin S; Cetin HO; Tek M; Gokaslan S; Amasyali B; Berkalp B; Diker E; Aydogdu S
Arq Bras Cardiol; 2019 Dec; 113(6):1129-1137. PubMed ID: 31664316
[TBL] [Abstract][Full Text] [Related]
17. Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.
Leibundgut G; Gick M; Morel O; Ferenc M; Werner KD; Comberg T; Kienzle RP; Buettner HJ; Neumann FJ
Clin Res Cardiol; 2016 May; 105(5):432-40. PubMed ID: 26563201
[TBL] [Abstract][Full Text] [Related]
18. Non-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction?
Khurelsukh K; Kim YH; Seon HJ; Song JH; Park SY; Moon SM; Kim SH; Sim DS; Ahn Y
Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():147-54. PubMed ID: 27139462
[TBL] [Abstract][Full Text] [Related]
19. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.
Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
